All posts tagged "Phase"
-
43Health CareAmylyx Pharma’s ALS drug needs a Phase 3 study to support FDA submission
Amylyx Pharmaceuticals is preparing to seek regulatory approvals for its amyotrophic lateral sclerosis drug in Europe and Canada later this year,...
-
11Health CareAmazon gives out $12M under next phase of AWS diagnostics development initiative
Amazon said on Monday that it is launching the next phase of its Amazon Web Services Diagnostic Development Initiative, in which it...
-
12Health CareEpic-Humana partnership enters new phase focused on prior authorizations
A year-and-a-half into their partnership, EHR developer Epic and health insurer Humana are expanding the scope of their work together. The companies...
-
104DiabetesThe SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes
AbstractOBJECTIVE Despite advances in exogenous insulin therapy, many patients with type 1 diabetes do not achieve acceptable glycemic control and remain at...
-
25Diabetes
Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial
AbstractOBJECTIVE The aim of this study was to investigate the efficacy and safety of imeglimin, the first in a new class of...
-
302Health NewsNovavax Reports Its COVID-19 Vaccine is 96% Efficacious, Based on Phase 3 Trial Results
Novavax reported on March 11 that its COVID-19 vaccine is 96% efficacious in reducing mild, moderate or severe disease. The Maryland-based company...
-
45Health CareVir Biotechnology, GSK Covid-19 antibody shows ‘profound efficacy’ in Phase 3 study
A Covid-19 drug candidate from Vir Biotechnology and GlaxoSmithKline has posted clinical trial results showing the treatment reduced the rate of...
-
111Health CareEli Lilly’s authorized Covid-19 antibody racks up more positive Phase 3 data
Eli Lilly has additional data from tests of its Covid-29 antibody drug and the results look even better than what was...
-
33Health NewsCognito Therapeutics touts positive Phase 2 results for device-delivered Alzheimer’s treatment
Yesterday Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, announced Phase 2 trial results suggesting its gamma...
-
63Health CareTakeda to pay Ovid $196M for full rights to Phase 3-ready epilepsy drug
When Takeda Pharmaceutical and Ovid Therapeutics began working together four years ago, the partners aimed to share in the development of a...
-
25Health CareNIH, partners commit $74.9M to new phase of Alzheimer’s program
The US National Institutes of Health and a coalition of private-sector partners are committing nearly $74.9 million to Alzheimer’s disease research over...
-
16Health CareAstraZeneca pulls Imfinzi in bladder cancer, nearly one year after Phase 3 miss
AstraZeneca’s immunotherapy Imfinzi is a blockbuster drug but it won’t be generating U.S. sales in bladder cancer anymore. The British pharmaceutical...
-
839Health CareThe Next Phase of Vaccine Distribution: High-Risk Medical Conditions
Individuals with certain medical conditions are at increased risk of severe illness1 if they become infected with SARS-CoV-2, the virus that causes...
